Medical Research Spending: The $68 Billion Lie
war-on-disease, 1-percent-treaty, medical-research, public-health, peace-dividend, decentralized-trials, dfda, dih, victory-bonds, health-economics, cost-benefit-analysis, clinical-trials, drug-development, regulatory-reform, military-spending, peace-economics, decentralized-governance, wishocracy, blockchain-governance, impact-investing
Here is the complete accounting of humanity’s commitment to curing disease. Spoiler: It’s largely an accounting trick.
The Broad Number vs. The Real Number
Governments love to claim they spend billions on “medical research.” In 2024, the official global total for government medical R&D was approximately $68 billion.
It sounds like a lot. It is a lie.
The Accounting Trick
That $68 billion figure includes: 1. Basic Science: Studying fruit fly genetics and yeast cells (important, but not a cure). 2. Overhead: University buildings, admin salaries, and electricity bills (often 40-60% of grants). 3. Bureaucracy: Salaries for the people who decide where the money goes. 4. Epidemiology: Counting how many people have died (instead of saving them).
The Real Number: $4.5B
When you strip away the overhead and basic science to ask “How much do governments spend on actually testing cures in humans?” the number collapses.
Global government spending on interventional clinical trials is only ~$4.5B per year.
That is the entire public contribution to testing new medicines for 8 billion people.
The Industry Trap
“But doesn’t the pharmaceutical industry fund trials?”
Yes. In fact, industry funds ~90% of all interventional trials. The ratio of Industry to Government spending is 17.4:1.
This creates a fatal incentive structure: 1. Profit First: Companies only test drugs that can be patented and sold for high prices. 2. Me-Too Drugs: It is safer to make the 12th slightly better antidepressant than to cure Alzheimer’s. 3. Orphan Diseases: If a disease doesn’t affect enough rich people, it gets zero funding. 4. Repurposed Generics: There is zero profit in proving that a cheap, off-patent drug cures cancer. So nobody funds those trials.
We have outsourced our survival to a business model that requires us to stay sick enough to buy pills, but alive enough to pay for them.
Broad R&D Breakdown: The Hall of Shame
Note: These figures refer to the broader “Medical Research” budgets (the $68B figure), not the specific clinical trial spending.
United States: The Alleged Leader
NIH Budget (2024): $47.1 billion
- Actual Clinical Trials: Only ~$810M - $5.6B (depending on definition).
- Administrative Costs: 31% of the budget.
- Indirect Costs: Universities take 40-60% for overhead.
China: The Rising Power
Medical Research Spending: ~$15 billion
- Prioritizes surveillance technology over medical breakthroughs.
- Spends 97x more on domestic security than clinical research.
European Union
Horizon Europe Health Budget: €1.17 billion/year
- Per citizen: Less than the cost of a cup of coffee ($2.89/year).
- Individual countries like Germany ($6B) and France ($4B) add to this, but the total remains a fraction of their military budgets.
The Rest of the World
- Japan: $5 billion (Aging population, zero urgency).
- India: $3 billion ($2.14 per person).
- Russia: $800 million (Spend huge on nukes, pennies on health).
Conclusion: A Species-Wide Failure
We are the only species that pays for its own extinction while claiming it cannot afford its own survival.
- Global Military Spending: $2.72T
- Pet Food: $150 Billion
- Video Games: $180 Billion
- Government Clinical Trials: $4.5B
We value our dogs’ dinner 30x more than finding cures for our children.
The solution is the 1% Treaty: shifting just 1% of military spending ($27B) would increase global government clinical trial funding by 600%. We could run tens of thousands of pragmatic trials annually, breaking the industry monopoly on what gets tested and cured.